BACKGROUND: Based on in vitro studies, it has been hypothesized that 1,25-dihydroxy vitamin D (1,25-vit D) may promote weight gain in humans, but previous studies have demonstrated conflicting results regarding the association between serum 1,25-vit D and body mass index (BMI). AIM OF THE STUDY: To evaluate the relation between serum 1,25-vit D and BMI. METHODS: Two thousand one hundred and eighty-seven subjects, recruited from a metabolic and medical lifestyle management clinic, were included in a cross-sectional study. BMI, 25-hydroxy vitamin D (25-OH-vit D) and 1,25-vit D were measured. The cohort was divided according to BMI in five groups (<25, 25-29.9, 30-34.9, 35-39.9 and >39.9 kg/m(2)). Statistical analyses were performed with multiple linear regression models. Age and gender were used as explanatory covariates. RESULTS: With increasing BMI group, there was a significant decrease in both serum 25-OH-vit D and 1,25-vit D (P<0.001). Those with BMI >39.9 kg/m(2) had 24% lower serum 25-OH-vit D levels and 18% lower 1,25-vit D levels than those with BMI <25 kg/m(2). CONCLUSIONS: There is an inverse association between BMI and the serum levels of 25-OH-vit D and 1,25-vit D. This makes it highly unlikely that high levels of circulating 1,25-vit D contribute to the development of obesity.
BACKGROUND: Based on in vitro studies, it has been hypothesized that 1,25-dihydroxy vitamin D (1,25-vit D) may promote weight gain in humans, but previous studies have demonstrated conflicting results regarding the association between serum 1,25-vit D and body mass index (BMI). AIM OF THE STUDY: To evaluate the relation between serum 1,25-vit D and BMI. METHODS: Two thousand one hundred and eighty-seven subjects, recruited from a metabolic and medical lifestyle management clinic, were included in a cross-sectional study. BMI, 25-hydroxy vitamin D (25-OH-vit D) and 1,25-vit D were measured. The cohort was divided according to BMI in five groups (<25, 25-29.9, 30-34.9, 35-39.9 and >39.9 kg/m(2)). Statistical analyses were performed with multiple linear regression models. Age and gender were used as explanatory covariates. RESULTS: With increasing BMI group, there was a significant decrease in both serum 25-OH-vit D and 1,25-vit D (P<0.001). Those with BMI >39.9 kg/m(2) had 24% lower serum 25-OH-vit D levels and 18% lower 1,25-vit D levels than those with BMI <25 kg/m(2). CONCLUSIONS: There is an inverse association between BMI and the serum levels of 25-OH-vit D and 1,25-vit D. This makes it highly unlikely that high levels of circulating 1,25-vit D contribute to the development of obesity.
Authors: Barbara Prietl; Gerlies Treiber; Julia K Mader; Evelyne Hoeller; Michael Wolf; Stefan Pilz; Winfried B Graninger; Barbara M Obermayer-Pietsch; Thomas R Pieber Journal: Eur J Nutr Date: 2013-09-03 Impact factor: 5.614
Authors: Ellen T Chang; Alison J Canchola; Myles Cockburn; Yani Lu; Sophia S Wang; Leslie Bernstein; Christina A Clarke; Pamela L Horn-Ross Journal: Blood Date: 2011-05-26 Impact factor: 22.113
Authors: Elizabeth Grethen; Kathleen M Hill; RoseMarie Jones; Brenda M Cacucci; Christine E Gupta; Anthony Acton; Robert V Considine; Munro Peacock Journal: J Clin Endocrinol Metab Date: 2012-02-22 Impact factor: 5.958
Authors: Kaye E Brock; Wen-Yi Huang; David R Fraser; Liang Ke; Marilyn Tseng; Rebecca S Mason; Rachael Z Stolzenberg-Solomon; D Michal Freedman; Jiyoung Ahn; Ulrike Peters; Catherine McCarty; Bruce W Hollis; Regina G Ziegler; Mark P Purdue; Barry I Graubard Journal: Br J Nutr Date: 2011-05-17 Impact factor: 3.718
Authors: Christine Dalgård; Maria Skaalum Petersen; Anne V Schmedes; Ivan Brandslund; Pal Weihe; Philippe Grandjean Journal: Br J Nutr Date: 2010-05-05 Impact factor: 3.718
Authors: W Zhou; L Langsetmo; C Berger; S Poliquin; N Kreiger; S I Barr; S M Kaiser; R G Josse; J C Prior; T E Towheed; T Anastassiades; K S Davison; C S Kovacs; D A Hanley; E A Papadimitropoulos; D Goltzman Journal: J Musculoskelet Neuronal Interact Date: 2013-12 Impact factor: 2.041
Authors: Susan Cheng; Joseph M Massaro; Caroline S Fox; Martin G Larson; Michelle J Keyes; Elizabeth L McCabe; Sander J Robins; Christopher J O'Donnell; Udo Hoffmann; Paul F Jacques; Sarah L Booth; Ramachandran S Vasan; Myles Wolf; Thomas J Wang Journal: Diabetes Date: 2009-10-15 Impact factor: 9.461